Overview

Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel

Status:
Completed

Trial end date:
2018-03-18

Target enrollment:

Participant gender:

Summary

This is a single center, open label, single sequence, two treatment, two-period drug-drug interaction study to evaluate the effect of multiple doses of ISIS 681257 on the pharmacokinetics of multiple doses of clopidogrel

Phase:

Phase 1

Details

Lead Sponsor:

Akcea Therapeutics

Treatments:

Clopidogrel